Scientists from Tübingen and Stockholm haven discovered high levels of ApoE protein in the cerebrospinal fluid of patients suffering from dementia. The ApoE protein is associated with a severe course of this disease.

Scientists at the Cluster of Excellence Inflammation at Interfaces, the Universität zu Lübeck (UzL) and international work groups have for the first time described the active reaction of intercellular channels (gap junctions) to bacterial toxins.

From 16 to 21 February 2014, the Helmholtz Institute for Pharmaceutical Research Saarland and Saarland University of Saarland will host the International Conference and Workshop on Biological Barriers.

Scientists from Regensburg together with collegues from Heidelberg and Lisboa have found a new approach against cystic fibrosis. For their investigations they used airway epithelial cells from CF patients.

The animal rights organisation PETA (PETA USA, PETA UK and their sister organisations in Europe and Asia) has founded a pioneering international life science department, PETA International Science Consortium, Ltd. (PISC).

The chinese regulations for cosmetics testing are in force since 1990. The chinese government is submitting proposals to enable companies to market cosmetics in China without testing on animals.

Scientists from the International Multiple Sclerosis Genetics Consortium (IMSGC) have identified 48 new gene variants that influence the risk of developing multiple sclerosis. The investigation was conducted using the new ImmunoChip technology.

The Julius Wolff Institute at Charité – Universitätsmedizin Berlin and the Wyss Institute for Biologically Inspired Engineering at Harvard University, United States) have signed an agreement to collaborate closely in the future.

Organ combination on a microchip

Tuesday, 24 September 2013 20:58

Researchers from the Wake Forest Institute for Regenerative Medicine led by Antony Atla have developed miniature human organs, using a modified 3D printer. They are now being used for testing new vaccines.

The University of Veterinary Medicine Hannover (TiHo) has developed a new method for simulating the development of fetal brain cells using human cancer cells. By administering toxic substances they can investigate their potential for impairing brain development.